Midlife weight gain is a persistent challenge for many women, but emerging research suggests hormone therapy may enhance response to glucagon-like peptide-1 (GLP-1)–based treatments.

A large new study found that the side effects of antidepressants vary significantly by drug. Some medications resulted in ...

Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular events.

Anti-obesity medication semaglutide may help to prevent heart attacks and other major cardiac events regardless of how much ...

An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in ...